Neurogene (NGNE) Reports In-Line Q3 EPS
Neurogene (NASDAQ: NGNE) reported Q3 EPS of ($1.19), in-line with the analyst estimate of ($1.19).
For earnings history and earnings-related data on Neurogene (NGNE) click here.
Neurogene (NASDAQ: NGNE) reported Q3 EPS of ($1.19), in-line with the analyst estimate of ($1.19).
For earnings history and earnings-related data on Neurogene (NGNE) click here.